The aim of coronavirus vaccination in Finland is to prevent serious cases of coronavirus infection, loss of life years, to maintain the carrying capacity of health care and to prevent premature deaths. More information on the resolution on Finland’s COVID-19 vaccine strategy by the Finnish Government in December 2020. (Valtioneuvosto.fi)
Who is eligible for the COVID-19 vaccination?
In Finland, COVID-19 vaccines will be acquired for the entire population and offered to anyone aged 5 or older.
A third dose of COVID-19 vaccine provides better protection against a serious form of COVID-19 than two doses, and can also prevent the spread of infection in younger age groups.
A third dose of COVID-19 vaccine is recommended for:
- persons with a severely weakened immune defence and aged 12 or over. More information on persons with a severely weakened immune defence (THL)
- persons who have been vaccinated with a short interval of less than 6 weeks and are aged 18 or over.
- all persons aged 60 and over.
- persons living in institutions and care homes and aged 18 or over.
- persons in medical high-risk groups 1 and 2 and aged 18 or over. List of medical at-risk groups (THL)
- health care personnel who treat coronavirus patients, personnel of 24-hour care facilities and other social welfare and health care personnel providing urgent care.
In addition, the Finnish Institute for Health and Welfare recommends that a third dose of COVID-19 vaccine be offered to all persons aged 18 and over.
More information on the vaccination order and at-risk groups (THL)
Where can I get vaccinated against COVID-19?
Municipalities are responsible for organising vaccinations in their own areas. In the vaccination process, municipalities can cooperate with each other, occupational health care services, private service providers and the local hospital district.
Mehiläinen's COVID-19 vaccinations are underway for customers of agreed municipalities and occupational health care.
In municipalities, Mehiläinen will participate in the vaccinations in a manner agreed upon separately with each municipality and offer the opportunity to vaccinate residents in all municipalities where it is possible.
Mehiläinen participates in COVID-19 vaccinations for occupational health care customers as agreed with each company. An employee can get a COVID-19 vaccination in Mehiläinen if the employer has agreed upon vaccinating their employees at Mehiläinen’s occupational health care services.
Check from Mehiläinen’s COVID-19 vaccination station information the municipalities whose residents and occupational health care customers the COVID-19 vaccination stations serve. In addition, you can also check the start of the third vaccinations.
The procurement of COVID-19 vaccines and organisation of the vaccinations
As Finland is involved in all European Union's joint procurements of COVID-19 vaccines, it has the opportunity to receive COVID-19 vaccines from various manufacturers. The procurement of vaccines is the responsibility of the Ministry of Social Affairs and Health. The final decision on the vaccines to be procured will be made by the Government.
Municipalities are responsible for organising and communicating COVID-19 vaccinations and will specify where and when you can get a vaccination.
Therefore, you should follow your municipality's website and other communications and contact a health centre or occupational health care provider.
Given COVID-19 vaccinations at Mehiläinen
Content updated 25 January 2022.
Mehiläinen prepares to organise vaccinations regionally and communicates with its occupational health customers locally in each municipality once the provision of vaccinations has been agreed upon in the municipality in question. Employees of organisations operating in several municipalities are vaccinated according to the policy of their specific municipality.
Kela reimburses employers in occupational health care reimbursement class 1 for the costs of vaccination measures related to COVID-19 vaccines. An alternative to this is the upcoming temporary amendment to the Health Insurance Act, which will add COVID-19 vaccination reimbursement to reimbursements for medical expenses. The amount of the reimbursement is EUR 10. The remainder of the cost of the vaccination measure would be borne by the employer as an excess.
Mehiläinen will use the vaccines included in the national vaccination programme in accordance with the policies of THL.
Mehiläinen has started administering coronavirus vaccines to the occupational health care customers who have agreed upon vaccinating their employees at Mehiläinen’s occupational health care services.
Finland is involved in all of the COVID-19 vaccine procurement contracts of the EU, making the vaccines of several manufacturers available to Finns. The COVID-19 vaccines have been selected according to the expected efficacy, safety and probable supply schedule.
Currently, Finland is a party to all six COVID-19 vaccine agreements negotiated by the European Commission.
In the EU and in Finland, COVID-19 vaccinations have begun with the mRNA COVID-19 vaccine developed by BioNTech and Pfizer.
In addition, Finland is involved in the procurement of vaccines from at least the following manufacturers.
- Johnson & Johnson
Learn more about COVID-19 vaccination arrangements (THL)
mRNA COVID-19 vaccines contain messenger RNA (mRNA) to cause the muscle cells at the injection site to produce the active substance of the vaccine, in other words the surface protein of the coronavirus.
The body's defence system reacts by recognising the surface protein as foreign, after which the defence system starts to produce an antibody against the surface protein. This teaches the body to fight the actual coronavirus if a COVID-19 virus enters the body.
Learn more about mRNA vaccines (THL)
The COVID-19 vaccination is free of charge to anyone living in Finland.
At Mehiläinen, the customer is only charged for the work related to the vaccination, unless the municipality has agreed to cover the costs of vaccination measures in private health care.
Private health care providers follow the same national order of vaccinating target groups as municipal vaccination centres.
Most municipalities are currently vaccinating at-risk groups and have started vaccinating population groups in a descending order of age.
Due to the limited data available, COVID-19 vaccinations are currently only recommended to pregnant women on an individual basis.
Learn more about COVID-19 vaccines, pregnancy and breastfeeding (THL)
The COVID-19 vaccination is voluntary for everyone.
The COVID-19 vaccines are assessed according to the same quality, safety and efficacy criteria as any other vaccines and medicinal products. Only those vaccines with research-based evidence of safety and efficacy are granted a sales permit by the authorities.
In Finland, the safety of COVID-19 vaccines is monitored by collecting data from reports on adverse reactions, safety reviews and research. The Finnish Medicines Agency Fimea collects information on suspected adverse reactions to COVID-19 vaccines and distributes information to THL and the European Medicines Agency.
Learn more about the safety of the COVID-19 vaccine (THL)
All vaccines, including the COVID-19 vaccine, may have side effects. Local symptoms such as a warm sensation, swelling, redness and pain may occur at the injection site after vaccination. Local reactions are more common after the second dose of the vaccine.
In addition, temporary symptoms such as headache, fatigue, irritability, nausea, chills and fever may occur.
Local and general symptoms usually occur within a couple of days after vaccination. The symptoms should pass in a few hours or days. Generally, the majority of adverse reactions to vaccines occur within six weeks after vaccination. The symptoms can be treated with painkillers and antipyretics, such as paracetamol, ibuprofen and naproxen.
Local and general symptoms do not prevent further vaccinations.
Learn more about the safety and adverse effects of the COVID-19 vaccine (THL)
The exact duration of immunity provided by COVID-19 vaccines is not yet known as there is no data on the long-term use of the vaccines. According to current information, the COVID-19 vaccines also have an effect on the different strains of the coronavirus.
In Finland, COVID-19 vaccines will be procured for the whole population, and since the vaccines are being obtained gradually, it will take some time to vaccinate every Finn.
The start of vaccinations does not mean that Finns will immediately be able to return to normal life. This is affected by the efficacy of the vaccines and their ability to prevent the more severe forms of COVID-19 and reduce the infection rates of the coronavirus. No precise information is yet available on the duration of the immunity provided by the vaccines.
In addition, it will take a long time after the start of the vaccinations before population-level immunity against the disease is reached and the epidemic is contained.
Learn more about the current situation of the COVID-19 epidemic (THL)
After COVID-19 vaccination, it is still important to keep a safe distance from others, wash your hands and cough into a tissue or your sleeve.
We recommend wearing a mask even after receiving the COVID-19 vaccine, especially when it is not possible to keep a safe distance.
In addition, after receiving the COVID-19 vaccine, we recommend continuing to monitor your health and, if any symptoms occur, getting tested and following any other instructions on preventing the spread of COVID-19 infections.
Learn about quick access to COVID-19 testing.
Learn more about how to prevent the spread of COVID-19 infections (THL)
According to current information, the majority of people affected by COVID-19 are protected for at least six months. In that case, the need for vaccination is not urgent.
Learn more on the THL website .
If you have had COVID-19, it does not prevent you from getting vaccinated. The vaccine has also been shown to be effective in people who have had COVID-19 in the past.
The COVID-19 vaccine has not been shown to be harmful even if the person to be vaccinated has an asymptomatic COVID-19 infection or has been recently infected but has not yet experienced any symptoms.
Learn more about vaccination requirements (THL)
There are usually no obstacles to getting vaccinated against COVID-19. People with an underlying condition can get vaccinated. Due to the limited data available, COVID-19 vaccinations are currently only recommended to pregnant women on an individual basis.
If a severe allergic reaction, known as anaphylaxis, occurs immediately after vaccination, the same vaccine or another vaccine containing the same ingredients is not administered again.
Learn more about the suitability of the COVID-19 vaccine (THL)
The COVID-19 antibody test measures the blood for antibodies called N-antigens that are produced as a result of a disease caused by the coronavirus. These antibodies are a sign of an ongoing or recent infection in the body caused by the coronavirus.
After vaccination, an antibody called S-antigen is formed. This antigen is not detected by the currently used antibody test.
COVID-19 vaccinations organised at Mehiläinen depend on the municipality in question. Municipalities are responsible for vaccinations, and the contracts made by Mehiläinen vary considerably. Some municipalities enable the vaccination of employees in their area, whereas some municipalities have limited the vaccinations to their residents.
Yes, if the company’s offices have concluded an agreement with their specific municipalities concerning COVID-19 vaccinations. In that case, the company receives Kela reimbursement for the vaccinations. A representative of the company can contact the occupational health contact person for drawing up a contract.
If you are vaccinated against COVID-19 at Mehiläinen, you will find your COVID-19 vaccination certificate in the OmaMehiläinen app where you can print it out.